Plasma P selectin (GMP-140) and glycocalicin are elevated in preeclampsia and eclampsia: Their significances

This publication has 21 references indexed in Scilit:

• Blood Coagulation and Fibrinolysis in Eclamptic Patients and Their Correlation with the Clinical Signs
  Gynecologic and Obstetric Investigation, 1995
• Soluble P‐selectin is present in normal circulation and its plasma level is elevated in patients with thrombotic thrombocytopenic purpura and haemolytic uraemic syndrome
  British Journal of Haematology, 1993
• Characterization of GMP-140 (P-selectin) as a circulating plasma protein.
  The Journal of Experimental Medicine, 1992
• The Relationship between Clinical Signs and Hypercoagulable State in Toxemia of Pregnancy
  Gynecologic and Obstetric Investigation, 1991
• Prevention of Activated Neutrophil Adhesion to Endothelium by Soluble Adhesion Protein GMP140
  Science, 1990
• Rapid neutrophil adhesion to activated endothelium mediated by GMP-140
  Nature, 1990
• PADGEM protein: A receptor that mediates the interaction of activated platelets with neutrophils and monocytes
  Cell, 1989
• GMP-140, a platelet alpha-granule membrane protein, is also synthesized by vascular endothelial cells and is localized in Weibel-Palade bodies.
  Journal of Clinical Investigation, 1989
• Increased platelet reactivity in pregnancyinduced hypertension and uncomplicated diabetic pregnancy: an indication for antiplatelet therapy?
  BJOG: An International Journal of Obstetrics and Gynaecology, 1988
• Enhanced platelet release reaction related to arterial plasma adrenaline and blood pressure in pre‐eclampsia
  BJOG: An International Journal of Obstetrics and Gynaecology, 1986